IPO News & Commentary
Get the latest insights on new stocks
- Emerging markets fintech OPay sets terms for $320 million US IPO 10/23/26
- Switzerland-based respiratory biotech Windward Bio Group files for a $100 million US IPO 10/23/26
- Lycia Therapeutics prices upsized IPO at $18, the high end of the range 10/23/26
- Inflammatory diseases biotech Rezera files for an estimated $100 million IPO 10/21/26
- China-based AI vision solutions provider Sensing4D AI files for a $35 million US IPO 10/21/26
- Africa-linked IPOs pick up steam in 2026 10/20/26
- Allergy and autoimmune biotech Lycia Therapeutics sets terms for $250 million IPO 10/20/26
See more
IPO News By Industry
- Christian-focused connectivity firm Patriot Mobile files for a $10 million IPO 10/09/26
- Hong Kong-based marketing firm AM PM Group doubles shares offered ahead of $34 million US IPO 08/27/26
- Hong Kong digital marketing provider Poche Technology ups range to $5 to $7 ahead of $38 million US IPO 08/06/26
NYSE IPO News
- US IPO Week Ahead: Africa-focused fintech target’s week sole IPO as Anthropic nears its public filing 10/23/26
- Emerging markets fintech OPay sets terms for $320 million US IPO 10/23/26
- Africa-linked IPOs pick up steam in 2026 10/20/26
- Pan-Asian travel booking platform Klook Technology withdraws estimated $400 million US IPO 10/16/26
- IPO Weekly Weigh-in: Why investors said no to this $3.5B AI IPO 10/14/26
Nasdaq IPO News
- US IPO Weekly Recap: Trickle of biotech activity continues amid tech sell-off 10/23/26
- SPAC: BHAV Acquisition II lowers deal size by 33% ahead of $100 million IPO 10/23/26
- Switzerland-based respiratory biotech Windward Bio Group files for a $100 million US IPO 10/23/26
- Lycia Therapeutics prices upsized IPO at $18, the high end of the range 10/23/26
- Inflammatory diseases biotech Rezera files for an estimated $100 million IPO 10/21/26
Be the in-house IPO Expert
Our clients are focused on catalyzing growth and creating value.
Not scouring the web for IPO data.
Get the information you need in minutes, not hours. With IPO Pro, you have the entire US IPO market at your fingertips.
US IPO Week Ahead: Africa-focused fintech target’s week sole IPO as Anthropic nears its public filing
One IPO is currently scheduled for the week ahead as investors continue to hold their breath for the year’s last potential mega IPO. Africa-focused digital bank and fintech platform OPay (OPAY) plans to raise $320 million at a $4.2 billion market cap....read more
US IPO Weekly Recap: Trickle of biotech activity continues amid tech sell-off
One biotech IPO debuted this week, while four IPOs submitted initial filings, including two sizable biotech filings. Allergy and autoimmune biotech Lycia Therapeutics (LYCA) priced its upsized IPO at the top of the range to raise $318 million at a $1.1...read more
SPAC: BHAV Acquisition II lowers deal size by 33% ahead of $100 million IPO
BHAV Acquisition II, a blank check company targeting robotics, EVs, fintech, advanced computing and energy tech, lowered the proposed deal size for its upcoming IPO on Friday. The Piscataway, NJ-based company now plans to raise $100 million by offering 10...read more